Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
Hematologic Oncology Update - Un pódcast de Research To Practice
Categorías:
Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.
